PANTHERx is pleased to announce the receipt of another Pittsburgh Business Times Best Places to Work Award, adding to a history of success.

PANTHERx is not afraid to break molds, be nimble, and reimagine programs for better outcomes. This flexibility has always served the organization well, but it is particularly crucial during this time, when communication and teamwork are more essential than ever. Although many associates have been working remotely, PANTHERx continued to foster a positive working environment and collaborative culture, while delivering the same level of exceptional care to our patients. Winning this award is a clear indication that the associates continue to feel a strong sense of community and are pleased with our cumulative efforts in the face of the pandemic.

PANTHERx takes pride in the stated company values and is dedicated to living them every day. The positive-mindset culture fosters the building of relationships in remote work environment while developing skills as both individuals and teams. As a ultra-fast-growing company, PANTHERx will continue to adapt so that employees feel constantly supported and respected. At PANTHERx the #1 priority is making sure our patients are fully satisfied, and the best way to do that is by taking care of the people that directly impact rare patients; the PANTHERx associates.

About Best Places to Work
The Best Places to Work Award provides employees with an opportunity to consider, rate, and comment on the culture of their companies. Consideration for this award is afforded to companies whose employees undergo a detailed survey process and subsequent response review. The companies that receive the highest scores are recognized as having positive workplace environments and cultures. Awards for the 2020 Best Places to Work winners will be announced during a virtual ceremony held by the Pittsburgh Business Times on December 3rd, 2020.

About PANTHERx® Rare Pharmacy
PANTHERx Rare Pharmacy, the largest independent and fastest growing specialty pharmacy in the United States, transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to patients afflicted with rare and devastating conditions. Although the incidence is as common as diabetes, less than 7% of the 7,000 known rare and devastating disorders have an approved therapy. Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community.

PANTHERx was recently awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) and earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). PANTHERx is a three-time winner of the prestigious MMIT Patient Choice Award including the 2020 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania, licensed in all 50 states, and holds accreditations from URAC, NABP, ACHC, and CPPA.

Smart Business Magazine has announced that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was selected as a 2020 Smart 50 Award honoree. Since 2014, the Pittsburgh Smart 50 Awards have recognized the top executives from the 50 smartest companies in the Greater Pittsburgh region. Honorees are selected for their ability to effectively build and lead successful organizations, and for their exemplary performance in the areas of innovation, impact, and sustainability. This is Dr. Vanscoy’s second appearance on the Smart 50 list. He was previously honored as an awardee in 2016.

With Pittsburgh’s advances in the industries of health care, education, and software engineering in recent decades, our city has become a hub of innovation. Companies in our region are paving the way for green initiatives, inclusive management structures, unique leadership styles, and positive corporate cultures. This year’s Smart 50 Program was incredibly rigorous with nearly 100 applicants.

“I am humbled to be named a 2020 Smart 50 Honoree,” said PANTHERx & RareMed’s Chairman & CEO, Dr. Gordon J. Vanscoy. “The award is a cause for celebration in the midst of tumultuous times and for recognizing my incredible leadership teams, and all of the associates at both PANTHERx Rare and RareMed Solutions. I am proud to lead two Pittsburgh-based national companies that are innovatively affecting positive change, not only in the Pittsburgh region, but on the broad rare disease community.”

Gordon will be celebrated during a special virtual event on November 19, 2020. All 50 honorees will be introduced, and three organizations will be singled out to win specialty awards for their achievements in the categories of impact, innovation, and sustainability. Additionally, all guests will have the opportunity to hear from this year’s keynote speaker about what it takes to lead a successful “smart” company.

Click here to learn more about the Smart 50 Awards & the Virtual Event on November 19th, 2020.

Ernst & Young LLP (EY US) announced today that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was named a 2020 Entrepreneur of The Year® East Central Award winner. As a regional award winner, Dr. Vanscoy is eligible for consideration for the Entrepreneur of The Year National Awards, to be announced in November during a virtual awards gala. The Entrepreneur of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur of The Year™ Award in June 2021.

Entrepreneur of The Year is a preeminent competitive award programs for entrepreneurs and leaders of high-growth companies. The nominees are evaluated based on six criteria, including overcoming adversity; financial performance; societal impact and commitment to building a values-based company; innovation; and talent management. Since its launch, the program has expanded to recognize business leaders in more than 145 cities in over 60 countries around the world.

Entrepreneur of The Year Award winners become lifetime members of a global, multi-industry community of entrepreneurs, with exclusive, ongoing access to the experience, insight and wisdom of program alumni and other ecosystem members in over 60 countries.

Follow PANTHERx & RareMed on our blogs and through our social media channels to learn about Dr. Vanscoy’s ongoing participation in the EY Entrepreneur of the Year Awards.

Sponsors

Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are nationally sponsored by SAP America and the Kauffman Foundation.

In East Central, sponsors also include PNC Bank, VRC, Morgan Lewis, Oswald Companies, and Smart Business.

About Entrepreneur of The Year^®

Entrepreneur of The Year^® is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. Winners go on to compete for the EY World Entrepreneur of The Year™ title. ey.com/us/eoy

About EY Private

As Advisors to the ambitious™, EY Private professionals possess the experience and passion to support private businesses and their owners in unlocking the full potential of their ambitions. EY Private teams offer distinct insights born from the long EY history of working with business owners and entrepreneurs. These teams support the full spectrum of private enterprises including private capital managers and investors and the portfolio businesses they fund, business owners, family businesses, family offices and entrepreneurs. Visit ey.com/private

About EY

EY is a global leader in assurance, tax, strategy, transaction and consulting services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. For more information about our organization, please visit ey.com.

In May of 2020 PANTHERx Rare Pharmacy shared the news that we had been officially recognized as a prestigious US Best Managed Company for overall business performance and sustained growth. The US Best Managed Company designation, sponsored by Deloitte Private and The Wall Street Journal, was, and is, the preeminent distinction for privately owned and managed businesses in the United States, based on criteria such as management abilities in the areas of strategy, execution, culture, financials, and overall business practices.

The leadership that earned us this award is the same leadership that has led us through the pandemic. We continue to look for ways to improve the employee, patient, and partner experience as we navigate work from home, digital communication, expanded technology, and our ever-present desire to maintain that human touch.

Recently, PANTHERx has had more reasons to celebrate, more reasons for our associates to feel proud, more reasons to believe that the measures we have taken during this global crisis were the right measures for our PANTHERx family.

Since May of 2020 we have:

• Graduated our 2020 Fellowship Class and brought on our 2021 Fellowship Class, the largest yet
• Added three unique rare medications to our portfolio
• Achieved the exclusive “Honor Roll Status” as an Inc. 5000 Fastest Growing Private Company in America for a 5^th Consecutive Year
• Celebrated the achievements of our Chairman & CEO, Dr. Gordon J. Vanscoy, as a 2020 East Central Award Finalist in EY’s Entrepreneur of the Year Awards Program

Just last week PANTHERx was named a 2020 Top Workplace by the Pittsburgh Post-Gazette. PANTHERx was the only pharmacy named as a top place to work across all three categories (large, midsize, and small). We were also the #1 rated health care company in the midsize category. PANTHERx was further named a winner of the Manager Award in the specialty award category, receiving top marks for the criteria, “My manager helps me learn and grow, my manager makes it easier to do my job well, my manager cares about my concerns.”

Each of the awards that PANTHERx earns brings tremendous gratification to our organization, the latest recognition from the Pittsburgh Post-Gazette holds even greater meaning as it was earned through the feedback from our employees.

PANTHERx Rare is proud to announce that it has been awarded a 2020 Top Workplaces by the Pittsburgh Post-Gazette. Awardees are determined by associate feedback to an anonymous survey facilitated by Energage. The survey measures 15 identified drivers of engaged cultures and successful organizations, including alignment, execution, and connection. This year PANTHERx is one of only 93 companies to make the Pittsburgh Post-Gazette’s List of Top Workplaces.

“PANTHERx has a rich history of success with ‘Top Workplaces Awards’. It is an immense point of pride for our organization and its leaders that our associates are happy to work at PANTHERx,” said Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare. “The deep roots of our culture and laser focus of our social mission has allowed PANTHERx’s workplace atmosphere to thrive, even during these times where we cannot be physically present with each other in the same capacity that we used to be. It is amazing that PANTHERx’s culture truly transcends the walls of our offices, and instead lives in each of our associates as they carryout their duties for the benefit of our rare disease patients.”

PANTHERx Rare will be recognized among other Pittsburgh Post-Gazette Top Workplace honorees at a virtual event in the coming weeks.

About PANTHERx Rare
PANTHERx Rare Pharmacy, the largest independent and fastest growing specialty pharmacy in the United States, transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to patients afflicted with rare and devastating conditions. Although the incidence is as common as diabetes, less than 7% of the 7,000 known rare and devastating disorders have an approved therapy. Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community.

PANTHERx was recently awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) and earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). PANTHERx is a three-time winner of the prestigious MMIT Patient Choice Award, including the 2020 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania, licensed in all 50 states, and holds accreditations from URAC, NABP, and ACHC.

About Energage
Energage offers a fully unified SaaS platform, plus support and professional services, to help organizations recruit and retain the right talent. As a B-Corporation founding member, Energage has committed itself to the purpose of making the world a better place to work together. Based on 14 years of culture research, the engine behind 51 Top Workplaces programs across the country, and data gathered from over 20 million employees at 60,000 organizations, Energage has isolated the 15 drivers of engaged cultures that are critical to the success of any business, and developed the tools and expertise to help organizations measure, shape and showcase their unique culture to achieve a sustainable competitive advantage. For more information, please visit energage.com.

Celebrating the unstoppable entrepreneurs whose ambitions transform our world

Ernst & Young LLP (EY US) announced today that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare, was named an Entrepreneur of The Year^® 2020 East Central Award finalist. Now in its 34th year, the Entrepreneur of The Year program honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they build and sustain successful businesses that transform our world. Dr. Vanscoy was selected as one of 26 finalists from nearly 100 nominations by a panel of independent judges.

Award winners will be announced through a special virtual event on October 7, 2020 and will join a lifelong community of esteemed Entrepreneur of The Year alumni from around the world. This year, unstoppable entrepreneurs who have provided extraordinary support for their communities, employees and others during the COVID-19 crisis will also be recognized for their courage, resilience and ingenuity.

Entrepreneur of The Year is one of the preeminent competitive award programs for entrepreneurs and leaders of high-growth companies. The nominees are evaluated based on six criteria, including overcoming adversity; financial performance; societal impact and commitment to building a values-based company; innovation; and talent management. Since its launch, the program has expanded to recognize business leaders in more than 145 cities in over 60 countries around the world.

Regional award winners are eligible for consideration for the Entrepreneur of The Year National Awards, to be announced in November during a virtual awards gala. The Entrepreneur of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur of The Year™ Award in June 2021.

Entrepreneur of The Year Award winners become lifetime members of a global, multi-industry community of entrepreneurs, with exclusive, ongoing access to the experience, insight and wisdom of program alumni and other ecosystem members in over 60 countries.

Sponsors

Founded and produced by Ernst & Young LLP, the Entrepreneur of The Year Awards are nationally sponsored by SAP America and the Kauffman Foundation.

In East Central, sponsors also include PNC Bank, VRC, Morgan Lewis, Oswald Companies, and Smart Business.

About Entrepreneur of The Year^®

Entrepreneur of The Year^® is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. Winners go on to compete for the EY World Entrepreneur of The Year™ title. ey.com/us/eoy

About EY Private

As Advisors to the ambitious™, EY Private professionals possess the experience and passion to support private businesses and their owners in unlocking the full potential of their ambitions. EY Private teams offer distinct insights born from the long EY history of working with business owners and entrepreneurs. These teams support the full spectrum of private enterprises including private capital managers and investors and the portfolio businesses they fund, business owners, family businesses, family offices and entrepreneurs. Visit ey.com/private

About EY

EY is a global leader in assurance, tax, strategy, transaction and consulting services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. For more information about our organization, please visit ey.com.

PANTHERx Rare Pharmacy announces that it has, for a 5th time, been named to the Inc. 5000 list, celebrating the fastest-growing private companies in America. PANTHERx is being recognized on this prestigious national list in the top 25% of fastest growing companies overall and the 83rd fastest growing company in Health.

Click here to view PANTHERx’s Inc. 5,000 profile.

About Our Inc. Standings
Over the last 40+ years, tens of thousands of companies have applied to the Inc. 5,000 and only a fraction have made the list more than once. This year PANTHERx Rare joins an exclusive group, the Inc. 5000 Honor Roll, recognizing companies that have made the list 5 or more times. PANTHERx’s standings over the last 5 years have included the following ranks; #1,154 (2020), #268 (2019), #49 (2018), #65 (2017), and #9 (2016).

“PANTHERx Rare is proud to be ranked on the Inc. 5,000 list for a fifth consecutive year. Although our magnitude of absolute growth is higher than ever, once you build a multi-billion dollar business, you can’t grow at the rates we did when we were smaller. In the time since PANTHERx made its debut on the Inc. 5,000 list we have opened a new state-of-the-art facility, launched a new brand, created a new industry (rare pharmacy), added numerous associates and partners to the PANTHERx family, and, most importantly, positively impacted the lives of tens of thousands of rare disease patients across the US,” said Dr. Gordon J. Vanscoy, Chairman and CEO. “We continue to innovative and advance the rare pharmacy industry, evolving to meet new challenges that address the needs of our partners, prescribers, and our patients.”

PANTHERx Rare will be recognized among other Inc. 5000 honorees at the Inc. 5000 Vision Conference, a weeklong virtual event and celebration, taking place October 19-23, 2020.

About PANTHERx Rare Pharmacy
PANTHERx Rare Pharmacy, the largest independent and fastest growing specialty pharmacy in the United States, transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to patients afflicted with rare and devastating conditions. Although the incidence is as common as diabetes, less than 7% of the 7,000 known rare and devastating disorders have an approved therapy. Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community.

PANTHERx was recently awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) and earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). PANTHERx is a three-time winner of the prestigious MMIT Patient Choice Award, including the 2020 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania, licensed in all 50 states, and holds accreditations from URAC, NABP, and ACHC.

In accordance with CDC guidelines, PANTHERx has taken a multitude of steps and implemented safety measures for the health and wellbeing of our patients, associates, and their families.

Over the last several months, we have announced or reported changes to policies and procedures as they have arisen. We are grateful for the flexibility and adaptability of our PANTHERx team and remain confident that we will continue to provide excellent care to our patients, service to our partners, and support to our associates.

In order to remain transparent with our stakeholders, PANTHERx would like to share the following additional enhanced safety measures that have been implemented in our facilities:

1. All onsite visitors including associates, delivery personnel, etc. receive a mandatory health check & temperature screening upon entering the facility.
2. Our pharmacy has been fitted with improved protective barriers to distance pharmacists from each other.
3. In additional to our typical janitorial practices and expanded associate cleaning initiatives, we have implemented hospital grade disinfectant fogging in our pharmacy.

The leadership at PANTHERx Rare continues to closely monitor the ongoing developments related to the concerns arising from the impact of COVID-19. As additional information becomes available and guidelines adapt, we will build and execute appropriate contingency protocols and provide details as necessary.

For more information about PANTHERx Rare’s COVID-19 response & action plan, please visit our homepage or click here.

PANTHERx Rare is proud to congratulate our Marketing Specialist, Ally Ayoob, on her recognition as a 2020 Pittsburgh Business Times 30 Under 30 honoree. Each year, The Pittsburgh Business Times identifies 30 individuals under the age of 30 years, who have accomplished exceptional career milestones and made great contributions to our Pittsburgh community. The 2020 honorees represent a wide range of industries, including rare pharmacy services, law, technology, manufacturing, and more.

“I am sincerely honored to be recognized by the Pittsburgh Business Times as a 30 Under 30 awardee,” said Ally Ayoob. “I share the honor with PANTHERx Rare, an organization whose brand and I have grown tremendously together over the past 2 years. I am proud of my efforts to reinvigorate PANTHERx’s brand, showcasing our authentic dedication to the rare disease community and our commitment to propelling the industry forward. Our brand reflects this now more than ever and I savor the challenge and opportunity of serving as it steward as we continue our mission to define rare and serve the people most in need of our care.”

Numerous previous recipients of the 30 Under 30 award continue to influence Pittsburgh’s businesses, serving as executives, innovators, and thought leaders in our organizations and communities. Click here to meet the 30 Under 30 Class of 2020.

About Ally Ayoob
As PANTHERx Rare’s Marketing Specialist, Ally leads the effort to create and share the company’s image and messaging to both internal associates as well as external prospects and stakeholders. Her creativity is demonstrated in PANTHERx Rare’s recent rebrand, the company’s new website, biopharma and payor presentations, physician campaigns, and patient materials. Her collaboration with all PANTHERx departments reveals her passion for PANTHER’s mission and vision, as well as her perseverance to achieve perfection in delivering the company’s message. Ally graduated from the University of Dayton in 2018 where she received her Bachelor of Science in Business Administration with degrees in Entrepreneurship and Marketing.

About PANTHERx Rare
PANTHERx Rare Pharmacy, the largest independent and fastest growing specialty pharmacy in the United States, transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to patients afflicted with rare and devastating conditions. Although the incidence is as common as diabetes, less than 7% of the 7,000 known rare and devastating disorders have an approved therapy. Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community.

PANTHERx was recently awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) and earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). PANTHERx is a three-time winner of the prestigious MMIT Patient Choice Award including the 2020 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania, licensed in all 50 states, and holds accreditations from URAC, NABP, ACHC, and CPPA.

At PANTHERx Rare Pharmacy we provide our patients with resources to support and streamline their health journeys. In addition to our 24/7 call services, PANTHERx has implemented a mobile messaging that offers onboarding messages, refill reminders, and shipment tracking information to our rare disease patients via text message.

Employing this texting platform has increased the effectiveness of our communication with our patients, allowing them to customize how they receive correspondence from us. The PANTHERx patients that have enrolled in the mobile messaging system find it to be a convenient way to receive reminders and stay on top of their medications. The platform has improved self-service success rates by simply delivering the specific tools and resources our patients need as part of their regular refill and shipping processes.

Becoming a user is simple. As a patient you’re able to enroll during your regularly scheduled refill calls. If you decline this mobile service at first and decide later that you would like to enroll, inform your Patient Care Coordinator at any time or during your next refill call. All of PANTHERx’s rare drug programs are currently eligible for enrollment in our texting program.

We want our patients to know that they are fully supported and that our services are able to be customized to fit their unique needs. PANTHERx feels strongly about guiding our patients through their health journeys and assisting them through multiple avenues of communication. Providing this mobile messaging service to our patients has allowed them to be more aware of their upcoming milestones and has also given our patients more flexible communication options.

For questions about PANTHERx’s mobile messaging service or to enroll in the program, please speak with your Patient Care Coordinator.